MarkMendelSklarMD

PubMed

• 107 citations
  Toward improved management of NIDDM: A randomized, controlled, pilot intervention using a lowfat, vegetarian diet.
  Andrew S Nicholson, Mark Sklar, Neal D. Barnard, Sarojini Gore, Rick Sullivan, Shaunagh Browning> ;Preventive Medicine. 1999 Aug 1

Journal Articles

• A Doctor’s Reflections on Health-Care Reform.  
  Sklar, Mark, The Wall Street Journal
• The Very-Low Fat, High-Fiber Diet in the Treatment of NIDDM: A Randomized, Controlled, Intervention Study.  
  Nicholson AS, Sklar MM, Gore S, Sullivan R, Browning S, Journal of Preventive Medicine
• Oral Hypoglycemics for NIDDM: Singly, Combined and With Insulin.  
  Khodor M, and Sklar, MM, Consultant; 35:361-372
• Developmental Expression of the Insulin-Like Growth Factor-II/Mannose 6-Phosphate Receptor.  
  Nissley P, Kiess W, Sklar MM, Molecular Reproduction and Development; 35:408-413
• Developmental expression of Rat Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor mRNA.  
  Sklar MM, Thomas CL, Municchi G, Robert CT, LeRoith D, Kiess W, Nissley SP, Endocrinology; 130:3484-3491
• Changes in the Expression of Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor During Endochondral Bone Development.  
  Yu YM, Sklar, MM, Nissley SP, Reddi AH, Biochem. Biophys. Res. Commun; 195:516-524
• Liver Regeneration Is Associated with Increased Expression of the Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor.  
  Burguera B, Werner H, Sklar MM, Shen O, Stannard B, Roberts CT, Nissley SP, Vore SJ, Caro JF, LeRoith D, Mol. Endocrinol; 4:1539-45
• Beta-Galactosidase Decreases the Binding Affinity of the Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor for Insulin-Like Growth-Factor II.  
  Kiess W, Thomas CL, Sklar MM, Nissley, SP, Eur. J. Biochem; 190:71-7
• Developmental Expression of the Tissue Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor in the Rat: Measurement by Quantitative Immunoblotting.  
  Sklar MM, Kiess W, Thomas CL, Nissley SP, J. Biol. Chem; 264:16733-8
• Insulin-Like Growth Factor-II (IGF-II) Inhibits Both the Cellular Uptake of Beta-Galactosidase and the Binding of Beta-Galactosidase to Purified IGF-II/Mannose-6-Phosp...  
  Kiess W, Thomas CL, Greenstein LA, Lee L, Sklar MM, Rechler, MM, Sahagian, GG, Nissley, SP, J. Biol. Chem; 264:4710-14
• Biochemical Evidence that the Type II Insulin-Like Growth Factor Receptor Is Identical to the Cation-Independent Mannose-6-Phosphate Receptor.  
  Kiess W, Blickenstaff GD, Sklar MM, Thomas CL, Nissley SP and Sahagian GC, J. Biol. Chem; 263:9339-44
• Join now to see all

Books/Book Chapters

• Insulin-Like Growth Factors: Molecular and Cellular Aspects. 
  Chapter: The Insulin-Like Growth Factor-II/Mannose-6-Phosphate Receptor 
  Page 111 - 150Nissley P, Kiess W, and Sklar MEditors: LeRoith D.CRC Press, Boca Raton

Abstracts/Posters

• Increased IGF-II Receptor Gene Expression and Binding During Liver Regeneration.
  Burguera B, Werner H, Sklar M, Roberts CT, LeRoith D, The American Diabetes Association Meetings
• The Rat Insulin-Like Growth Factor-II (IGF-II)/Mannose-6-Phosphate (M6P) Receptor mRNA Is Developmentally Regulated in Multiple Tissues.
  Sklar MM, Thomas CL, Municchi G, Kress W, Nissley SP, Endocrine Society
• Evidence that Beta-Galactosidase Inhibits Insulin-Like Growth Factor-II (IGF-II) Binding to the IGF-II/Mannose-6-Phosphate Recognition Site.
  Kiess W, Sklar MM, Thomas C, Nissley SP, Endocrine Society
• Insulin-Like Growth Factor-II (IGF-II) Inhibits Binding of Beta Galactosidase to the IGF-II/Mannose-6-Phosphate (M6P) Receptor.
  Kiess W, Sklar MM, Thomas CL, Lee L, Nissley SP, Endocrine Society
• The Rat Insulin-Like Growth Factor II (IGF-II)/Mannose-6-Phosphate (M6P) Receptor Is Developmentally Regulated in Multiple Tissues.
  Sklar MM, Kiess W, Thomas CL, Lee L, Nissley SP, Endocrine Society
• Join now to see all